4'-((2-BUTYL-4-OXO-1,3-DIAZASPIRO(4.4)NON-1-EN-3-YL)METHYL)-N-(4,5-DIMETHYL-3-ISOXAZOLYL)-2'-(ETHOXYMETHYL)-N-(METHOXYMETHYL)(1,1'-BIPHENYL)-2-SULFONAMIDE
UNII W7C3D5MQT5
Substance Identification & Data
This profile provides standardized clinical and technical data for 4'-((2-butyl-4-oxo-1,3-diazaspiro(4.4)non-1-en-3-yl)methyl)-n-(4,5-dimethyl-3-isoxazolyl)-2'-(ethoxymethyl)-n-(methoxymethyl)(1,1'-biphenyl)-2-sulfonamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) W7C3D5MQT5.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1026355-73-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C34H44N4O6S XYWGCTPPRWEYNN-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4'-((2-butyl-4-oxo-1,3-diazaspiro(4.4)non-1-en-3-yl)methyl)-n-(4,5-dimethyl-3-isoxazolyl)-2'-(ethoxymethyl)-n-(methoxymethyl)(1,1'-biphenyl)-2-sulfonamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.